Hepatocellular carcinoma is the most common liver cancer and ranks third in the world in terms of mortality. Its appearance is related to the hepatitis B and C viruses, alcoholism, metabolic diseases of the liver and exposure to certain toxins...
Read more
More information
Read more
The CIBBIM-Nanomedicine. Drug Delivery and Targeting Group of the Vall d’Hebron Research Institute (VHIR) has conducted a study to measure the effectiveness of Zileuton ™, a drug that is indicated for the treatment of asthma, administered...
Read more
Researchers from the CIBBIM-Nanomedicine Drug Delivery and Trageting of the Vall d’Hebron Research Institute (VHIR) and CIBER-BBN with Dr. Ibane Abasolo at the head, have studied the viability of the bacterial inclusion bodies as a method...
Read more
The Nanoparticle Design and Pharmacodynamics group focuses on the synthesis, characterisation and applications of inorganic nanoparticle engineering in the field of medicine. The group’s aim is to design nanoparticles that can interact with...
Read more
Yesterday evening, on the occasion of the Biologist’s Day, Dr. Anna Meseguer picked up the Research and Investigation Prize awarded by the College of Biologists of Catalonia in recognition of her contribution to scientific advances and the...
Read more
The Safe-N-Medtech initiative just kicked off last week in Bilbao, in a meeting hosted by Osteba, the HTA Unit of the Health Ministry of the Basque Country (Spain) in collaboration with BIOPRAXIS-BIOKERALTY. The project is coordinated by TECNAN...
Read more
After serving as editor-in-chief of Nanomedicine: Nanotechnology, Biology and Medicine for over seven years, Lajos Balogh knew that he had the skills and expertise needed to run an academic journal. An ardent open access (OA) advocate, Balogh...
Read more
On May 23, 2019, the Centre Tarraconense El Seminari will host the 11th Research Day organized by the Catalan Health Institute involving several researchers from the Vall d’Hebron Research Institute (VHIR). This year, is dedicated to...
Read more
The Vall d’Hebron Research Institute’s Oncology Department (VHIR) has organized the second mini-symposium ‘OMICs in Cancer Research’ in which speakers from different institutions and countries, reviewed the current state...
Read more
On the occasion of World Colorectal Cancer Day, this Sunday, March 31, CIBBIM-Nanomedicine. Biomedical Research in Digestive Tract Tumors of the Institut de Recerca Vall d’hebron (VHIR) wants to raise awareness among the population about...
Read more
Next Monday, November 19, Vall d’Hebron will hold a seminar focused on Lysosomal Rare Disorders: Focus on Fabry Disease. The seminar is part of the Rare Diseases Program at the Vall d’Hebron Campus, in collaboration with the European...
Read more
